University of California

Rm2 Technology LLC

Other

Angiodynamics, Inc.

Inter Science Gmbh

Cryomedical Sciences Inc.

The General Hospital Corporation

Cerebrotech Medical Systems, Inc.

Telectroscan, Inc.

Cryoelectric Science Ltd.

Boris Rubinsky

Paul W Mikus

Yong Huang

Liel Rubinsky

Rafael V Davalos

Cesar A Gonzalez

Antoni Ivorra

David A Benaron

Michael Klaus Stehling

Enric Günther

Elad Maor

James J Mitchell

J J Finkelstein

Dan Neu

John Gilbert

Grant Pease

Mitchell Elliott Levinson

Martin L Yarmush

Bryan Jon Weber

Gary M Onik

William C Hamilton

Ze'Ev Shaked

Steve Jones

Michal Adamkievicz

Mark Roos

Michael Belkin

William Gerald Austen, Jr

Richard Warren Wyeth

Robert L Sheridan

Alexander Golberg

Eugene Mark Shusterman

Amir Arav

Arthur L Devries

Sam Wong

G Felix Broelsch

Charlotte Daniels

San Wong

Amir-Homayoon Koushafar

Franco Lugnani

Gabriel Nastase

Mary Phillips

Gideon Ukpai

Guojiang Zhao

Matthew J Powell-Palm

Jacob Lavee

Nina Klein

Moshe Oziel

Jon Edd

Liana Horowitz

David Otten

The disclosure provides processes for temperature and pressure controlled cryopreservation of samples by using isochoric systems.

Process and device for temperature and pressure controlled cryopreservation

Supercooled water or solutions can be destabilized by the nucleation of ice. Constraining water in a constant-volume (isochoric) container minimizes destabilization through thermodynamic, kinetic, and fluid dynamic means, significantly enhancing supercooling stability. Methods and devices are used for stable and transportable supercooling of aqueous solutions or suspensions, and the stable and long-term preservation of biological matter that may be stored therein.

Devices and methods for high-stability supercooling of aqueous media and biological matter

Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis products to a site which may be used for treatment of infection and ablation of undesirable cells and tissue. A system disclosed may include a power supply, two electrodes, an aqueous matrix that may close the electric circuit between the electrodes at the treated site, and a controller. The controller may control the electrical circuit to induce a direct current through the electrodes and an aqueous matrix to produce electrolysis products. The duration and magnitude of the charge applied may determine the dose of the products applied to the treatment site. The composition of the electrodes and the aqueous matrix may be chosen to produce desired products. An apparatus is disclosed that may be in the form of a pad for applying to a wound. An apparatus is disclosed that may be used for treating internal tissue.

Methods, systems, and apparatuses for delivery of electrolysis products

Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A pulse that has an element of decay may be applied to a target for tissue ablation while the decay is modulated. In some examples, apparatus including a controller and switches may be used to modulate the decay and/or selectively apply the pulse to the target. The apparatus may further include resistors and/or other elements to modulate a magnitude of the pulse and/or a slope of a decay of the pulse.

Methods, systems, and apparatuses for tissue ablation using a modulated exponential decay pulse

Example apparatuses and systems are disclosed for providing controlled delivery of electrolysis treatment and cellular permeabilization treatment to a site in tissue. A system disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through the aqueous matrix to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site. The composition of the electrodes may be chosen in accordance with the desired products produced and electroporation effects. An apparatus is disclosed that may be in the form of electrodes for electrolysis and electrodes for electroporation applied to the tissue. An apparatus is disclosed that may be used for treating internal tissue.

Methods, systems, and apparatuses for tissue ablation using electrolysis and permeabilization

A cryosurgical instrument having a cryosurgical probe, at least one electrode configured to generate products of electrolysis, and a protective member coupled to at least a portion of an exterior surface of the cryosurgical probe effective to substantially isolate the cryosurgical probe from the products of electrolysis is disclosed. Methods of providing combined cryosurgical treatment and electrolysis with the cryosurgical instrument are disclosed. A system having the cryosurgical instrument, a cryogenic power supply, an electrolysis power supply, and a controller configured to generate a cryogenic signal and an electric signal is disclosed. Methods of producing the cryosurgical instrument by selecting a cryosurgical probe, coupling at least one electrode to the cryosurgical probe, and fastening the protective member to at least a portion of an exterior surface of the cryosurgical probe are disclosed. Cryosurgical probe protective devices are also disclosed.

Methods, systems, and apparatuses for cryosurgery, coldsurgery, and electrolysis

Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.

Methods, systems, and apparatuses for tissue ablation using pulse shape designs

Systems, apparatus and methods for producing objects with cryogenic 3D printing with controllable micro and macrostructure with potential applications in tissue engineering, drug delivery, and the food industry. The technology can produce complex structures with controlled morphology when the printed 3D object is immersed in a liquid coolant, whose upper surface is maintained at the same level as the highest deposited layer of the object. This ensures that the computer-controlled process of freezing is controlled precisely and already printed frozen layers remain at a constant temperature. The technology controls the temperature, flow rate and volume of the printed fluid emitted by the dispenser that has X-Y positional translation and conditions at the interface between the dispenser and coolant surface. The technology can also control the temperature of the pool of liquid coolant and the vertical position of the printing surface and pool of coolant liquid.

Systems, apparatus and methods for cryogenic 3D printing

A method for measuring an intracranial bioimpedance in a patient's head, to help evaluate cerebral autoregulation, may involve securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head, measuring the intracranial bioimpedance with the VIPS device by measuring a phase shift between a magnetic field transmitted from a transmitter on one side of a VIPS device and a magnetic field received at a receiver on another side of the VIPS device, at one or more frequencies, and evaluating cerebral autoregulation in the intracranial bioimpedance, using a processor in the VIPS device.

Continuous autoregulation system

A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable.

Tissue ablation with irreversible electroporation

Restenosis or neointimal formation may occur following angioplasty or other trauma to an artery such as by-pass surgery. This presents a major clinical problem which narrows the artery. The invention provides a balloon catheter with a particular electrode configuration. Also provided is a method whereby vascular cells in the area of the artery subjected to the trauma are subjected to irreversible electroporation which is a non-thermal, non-pharmaceutical method of applying electrical pulses to the cells so that substantially all of the cells in the area are ablated while leaving the structure of the vessel in place and substantially unharmed due to the non-thermal nature of the procedure.

Balloon catheter method for reducing restenosis via irreversible electroporation

Growing community of inventors

El Cerrito, CA, United States of America

Boris Rubinsky